尼拉帕尼
Niraparib (MK-4827)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Niraparib (MK-4827)
CAS1038915-60-4
FormulaC₁₉H₂₀N₄O
MW320.39
AppearanceWhite to light yellow powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

Niraparib, also known as MK4827, is an orally active, potent and selective poly(ADP-Ribose) polymerase (PARP) inhibitor that radiosensitizes human lung and breast cancer cells. Niraparib inhibits PARP1/PARP2 with IC50 of 3.8 nM/2.1 nM respectively. Niraparib is currently in Phase 3 clinical trials for ovarian cancer and BRCA+ breast cancer.

Related literature
Related
Sorry, no related items
History
Niraparib (MK-4827)
MMAD (Synonyms: Demethyldolastatin 10; Monomethylauristatin D; Monomethyl Dolastatin 10)
Fmoc-Nle-OH; N-α-Fmoc-L-norleucine/Fmoc-L-Norleucine
Ropinirole (Synonyms: SKF 101468)
MRT-10 (MRT 10)
Pelitinib (Synonyms: EKB-569; WAY-EKB 569)
Recombinant TEV Protease (rTEV)
BIX-01294 trihydrochloride | BIX01294 triHCl
Darolutamide | ODM-201 | BAY-1841788
Etoposide phosphate (Synonyms: BMY-40481)